Serina Therapeutics Inc (SER)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $36.93M
Last updated: Nov 17, 2026 at 11:04 AM ET
Serina Therapeutics Inc (SER) Stock Forecast
Analysts expect Serina Therapeutics (SER) to earn -$1.58 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$1.16.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$1.58
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$1.16
- EPS consensus
- Next report
- May 10, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$1.58 | -$1.76 to -$1.40 | 2 |
| Dec 31, 2027 | -$1.16 | -$1.33 to -$0.98 | 2 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.30 | -$0.32 to -$0.28 | 3 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 4 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 2 | 0 |
| Fiscal year ending Dec 31, 2027 | 2 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$1.95.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$1.58 | -$1.58 | -$1.58 | -$1.58 | -$1.95 | N/A |
| Fiscal year ending Dec 31, 2027 | -$1.16 | -$1.16 | -$1.16 | -$1.16 | -$1.57 | N/A |
Frequently Asked Questions About SER
What is the SER stock forecast?
Consensus analyst estimates put Serina Therapeutics's EPS at -$1.58 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from SER next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.58, with estimates from -$1.76 to -$1.40 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.16, with estimates from -$1.33 to -$0.98 from 2 analysts.
How many analysts cover SER?
2 analysts estimate EPS for Serina Therapeutics for the fiscal year ending Dec 31, 2026.
SER pages: Overview, Earnings, Forecast, Financials, Competitors